LabCompass

Sarah A. Reisinger

Medicine · The Ohio State University

Established · publishing since 2000

Publications

57

Citations

904

Est. group size

~20

Recurring co-author estimate

Active years

27

Publishing since 2000

Research summary
AI-generated

Sarah A. Reisinger's research focuses on tobacco and nicotine product use, examining how cigarette design features (like filter ventilation), alternative products (e-cigarettes, snus), and smoking cessation affect health-related biomarkers and behavior. Her work combines clinical trials and laboratory biomarker analysis (such as DNA damage markers and inflammation indicators) to understand exposure risks from smoking and reduced-risk tobacco products. This research is relevant to students interested in public health, addiction science, and tobacco regulatory science.

Tobacco and nicotine product useSmoking cessation and behavior changeBiomarkers of tobacco exposure and harmElectronic cigarettes and alternative nicotine productsClinical trials in addiction research

Publication output has been relatively steady over the last decade, fluctuating between roughly 3 and 8 papers per year without a clear long-term upward or downward trend.

Generated by claude-sonnet-5 from public bibliographic data · Jul 20, 2026

Publication cadence
Publications per year over the last 10 years — averaging 4.8/year recently
172018: 5 publications182019: 8 publications8192020: 4 publications202021: 8 publications8212022: 7 publications222023: 6 publications232024: 3 publications242025: 4 publications252026: 4 publications26
Publishes in
  • Cancer Research×5
  • medRxiv×3
  • Cancer Epidemiology Biomarkers & Prevention×2
  • Nicotine & Tobacco Research×2
  • Clinical Epigenetics×2
Similar researchers
By research-topic overlap

This profile was generated automatically from public scholarly data (OpenAlex). Group size and activity levels are estimates derived from co-authorship patterns.

Last updated Jul 19, 2026.

Claim or correct this profile